IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 12 analysts with an average price target of $36.79. This is a potential upside of $10.62 (40.58%) from yesterday's end of day stock price of $26.17.

Immunovant 's activity chart (see below) currently has 61 price targets and 84 ratings on display. The stock rating distribution of IMVT is 2.13% HOLD and 97.87% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.59% with an average time for these price targets to be met of 197.43 days.

Highest price target for IMVT is $52, Lowest price target is $36, average price target is $36.79.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 08-Nov-2024. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 1 are a HOLD (2.13%), 46 are a BUY (97.87%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$51

$24.37 (91.51%)

$51

12 days ago
(08-Nov-2024)

12/19 (63.16%)

$20.21 (65.64%)

279

Buy

$36

$9.37 (35.19%)

$40

1 months 10 days ago
(10-Oct-2024)

2/3 (66.67%)

$6.07 (20.28%)

35

Buy

2 months 11 days ago
(09-Sep-2024)

4/5 (80%)

$7.25 (19.21%)

113

Buy

$41

$14.37 (53.96%)

$56

3 months 7 days ago
(13-Aug-2024)

1/5 (20%)

$11.21 (37.63%)

3

Buy

$48

$21.37 (80.25%)

$48

7 months 26 days ago
(25-Mar-2024)

7/11 (63.64%)

$16.78 (53.75%)

275

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 197.43 days on average for the stock forecasts to be realized with a an average price target met ratio 71.59

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Yatin Suneja works at GUGGENHEIM and has 9 price targets and 5 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Yasmeen Rahimi with highest potential upside - $30.37

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$19.63

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?